Skip to main content
. 2018 Dec;30(4):265–269. doi: 10.5455/msm.2018.30.265-269

Table 2. Relationship between the stigma measured by rESS scale, demographic and clinical characteristics of the respondents.

rEES categories
0
(without stigma)
1-6
(mild stigma)
7-9
(high stigma)
p-
value
Sex
Male 7 (46.7%) 23 (45.1%) 15 (44.1%) 0.870#
Female 8 (53.3%) 28 (54.9%) 19 (55.9%)
Education level
Grammar school 0 (0.0%) 3 (6.0%) 1 (2.9%) 0.809#
High school 10 (66.7%) 33 (66.0%) 21 (61.8%)
College education 1 (6.7%) 8 (16.0%) 4 (11.8%)
University qualifications 4 (26.7%) 6 (12.0%) 8 (23.5%)
Employment
Employed 9 (60.0%) 26 (52.0%) 22 (64.7%) 0.538#
Unemployed 6 (40.0%) 24 (48.0%) 12 (35.3%)
BDI (0-63)
Median (interquartile range)
5 (1-8) 3 (0-8) 8 (0-24.5)
≤9 –without depression 12 (80.0%) 39 (76.5%) 18 (52.9%) 0.011
10-15 – mild depression 0 (0.0%) 3 (5.9%) 2 (5.9%)
16-19 – mild to moderate depression 1 (6.7%) 5 (9.8%) 4 (11.8%)
20-29 – moderate to expressed depression 2 (13.3%) 3 (5.9%) 4 (11.8%)
≥30 – expressed depression 0 (0.0%) 1 (2.0%) 6 (17.6%)
Type of seizures
Focal 9 (60.0%) 34 (66.7%) 24 (70.6%) 0.476#
Generalized 6 (40.0%) 17 (33.3%) 10 (29.4%)
The duration of disease/year
Median (interquartile range)
15 (8-18) 12 (8-20) 11 (6.5-18.5) 0.768*
Period without EPI seizure/months
Median (interquartile range)
6 (3-8) 4 (3-6) 6 (4-9) 0.026*
Age/years
Median (interquartile range)
33 (21-38) 36 (28-46) 41 (29-49.5) 0.369*
Therapy
Monotherapy 5 (33.3%) 7 (13.7%) 8 (23.5%) 0.430#
Polytherapy 10 (66.7%) 44 (86.3%) 26 (76.5%)